Skip to main content
. 2017 Nov 7;17(2):477–485. doi: 10.1177/1534735417734913

Table 2.

Tumoral Progression of Patients in the TACE + KA and TACE Groups.

Group Increased viable Tumoral Tissue Intrahepatic Metastasis Major Vascular Invasion Extrahepatic Metastasis
TACE + KA, n (%) 8 (16.7) 22 (45.8) 21 (43.8) 12 (25.0)
TACE, n (%) 9 (22.0) 28 (68.3) 24 (58.5) 19 (46.3)
P a .527 .033 .164 .035

Abbreviations: TACE, transarterial chemoembolization; KA, Kang’ai injection.

a

P value for comparison between TACE + KA and TACE groups.